arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

bioAffinity Technologies, Inc.

BIAF

$2.65 ▼ -0.38 (-12.42%) at close

6 Visible periods

29 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

bioAffinity Technologies, Inc. faces fundamental challenges with weakness in Return on Common Equity (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $4.6M

Dividend Yield —

Revenue Growth -34.2% ↘

Op. Margin -171.6% ↘

ROIC -145.7% ↗

FCF / Share $-5.46 ↗

Trailing P/E —

Price / Book 1.6x

FCF Yield —

Debt / Equity 0.02

info Valuation on last close. End-of-day price, Nov 5, 2026.

6-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$6.16M

↓ -34.2% —

Net Income Profit after all expenses

$-14.91M

↓ -64.9% —

Operating Margin Operating profit as % of sales

-171.6%

↓ -79.4% 1th

FCF / Share Free cash flow per share

$-5.46

↑ +70.0% —

trending_up

Bullish Indicators

Debt to EquityDebt to Equity is in the top quartile (lower is better)

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile
Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↓

Returns

Financial Health ↓

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗
Revenue Growth YoY (%)	-34.2% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-784%)	18.5% Good Good Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+270%)	14.5% Good Good Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+190%)	—	—	—
EPS Growth YoY (%)	61.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-2372.5% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	49.7% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	23.3% Good Good Year-over-year change in earnings per share Optimal: > 10%	—	—
Net Income Growth YoY (%)	-64.9% Weak ↓ Weak Declining Year-over-year change in net income	-13.9% Weak ↓ Weak Declining Year-over-year change in net income	2.7% Caution Caution Year-over-year change in net income	-28.9% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	70.0% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	-2522.6% Weak ↓ Weak Declining Year-over-year change in free cash flow	27.4% Excellent Excellent Year-over-year change in free cash flow	-24.5% Weak Weak Year-over-year change in free cash flow	—	—
Revenue CAGR 3Y (%)	-3.7% Weak Weak Compound annual revenue growth over 3 years	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗
Operating Margin (%) (%)	-171.6% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1530%)	-95.6% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-897%)	-100.9% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-941%)	-58.1% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-584%)	—	—
Effective Tax Rate (%) (%)	-0.3% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.3% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—
Profit Margin (%) (%)	-242.0% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3125%)	-96.6% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1307%)	-100.5% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1356%)	-118.2% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1577%)	—	—
FCF Margin (%) (%)	-152.4% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-78.4% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-76.7% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-62.2% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—
FCF / Net Income (x)	0.63x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.81x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.76x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.53x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.32x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗
Return on Invested Capital (%)	-145.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-344.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-164.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-36.3% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	14.0% Good Good Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-96.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-137.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-97.0% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-32.9% Weak Weak Operating profit relative to total assets Optimal: > 10%	-151.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	-204.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1466%)	—	-163.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1190%)	-73.8% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-592%)	40.1% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+167%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗
Debt to Equity (x)	0.02x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-97%)	—	—	—	—	—
Interest Coverage (x)	-240.06x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-768.54x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-214.77x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-1.58x Weak Weak Operating income divided by interest expense Optimal: > 5x	-2.20x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$-6.32M	$-1.11M	$-2.82M	$-11.41M	$-1.36M	—
Debt / EBITDA (x)	-0.01x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗
Revenue per Share (USD)	$3.58	$23.16	$0.90	$1.53	—	—
Basic EPS, GAAP (USD)	$-8.66	$-22.50	$-0.91	$-1.81	$-2.36	—
Free Cash Flow per Share (USD)	$-5.46	$-18.17	$-0.69	$-0.95	$-0.77	—
Book Value per Share (USD)	$1.62	$5.01	$0.52	$1.32	$-5.90	—
Tangible Book Value per Share (USD)	$1.15	$0.81	$0.28	$1.32	$-5.90	—
Basic Weighted Avg Shares (shares)	1.72M	404,167	8.75M	4.50M	2.68M	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗
Working Capital (USD)	$4.66M	$-409.81K	$1.72M	$10.82M	$-11.60M	—
Total Equity (USD)	$7.28M	$2.60M	$4.86M	$11.04M	$-15.79M	$-15.07M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗
Sales/Revenue/Turnover (USD)	$6.16M	$9.36M	$7.90M	$6.90M	—	—
Depreciation Expense (USD)	$170.36K	$162.33K	$233.06K	$10.18K	—	—
Net Income, GAAP (USD)	$-14.91M	$-9.04M	$-7.94M	$-8.15M	$-6.33M	—
Operating Cash Flow (USD)	$-9.33M	$-7.26M	$-6.04M	$-4.07M	$-2.05M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 6 years · 23 quarters

bioAffinity Technologies, Inc.

Analytical Summary

6-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare BIAF with peers